Invega Syringe Lawsuit | 2024 Latest Updates

Invega Syringe Lawsuit Overview

The Invega Syringe potential lawsuits involve Johnson & Johnson’s recall of approximately 70,000 Invega Sustenna syringes nationwide, announced in February 2011. These legal actions primarily allege that cracks in the syringes compromised sterility and could potentially cause infections or reduced medication efficacy. The recall affected specific lot numbers of the 234 mg strength with expiration dates ranging from 09/2011 to 05/2012, with some sample packs expiring 08/2012. This recall, in 2011, amid numerous product recalls in prior years, marked another significant issue for Johnson & Johnson.

Latest Invega Syringe Lawsuit Updates

August 14, 2024 – Latest update on the Invega Syringe recall litigation as Schmidt&Clark continues to accept new infection and reduced efficacy cases in all 50 states.

Related Articles:

• Medical Device Attorneys & Lawsuits Info
• HawkOne Directional Atherectomy System Litigation
• Endotracheal Tube Lawsuit

FDA Reports and Statistics

The recall of Invega Sustenna syringes, announced by Johnson & Johnson’s Janssen unit on February 15, 2011, was initiated following the discovery of potentially dangerous cracks in the syringes. These defects could:

• Compromise the sterility of the syringe contents
• Potentially result in local injection-site infections
• Possibly cause systemic infections
• Lead to a lower-than-intended therapeutic dose if the product is administered
  This recall specifically affected Invega Sustenna (paliperidone palmitate 234 mg) Extended-Release Injectable Suspension with NDC 50458-564-01 (lots 9IBK000, 9IBK001, 9IBK002, 9IBK003, 9IBK004, 9IBK005, 9JBK000; expiration dates 09/2011 to 12/2012) and sample packs with NDC 50458-564-03 (lots 9JBK000, 9JBK001, 9IBK000; expiration dates 12/2011 to 08/2012), as identified by Johnson & Johnson. 

Invega Syringe Injuries & Side Effects

Users of the recalled Invega syringes could experience several health complications due to the defective products:

• Injection-site infections: Localized pain, swelling, and potential tissue damage
• Systemic infections: Fever, chills, and potentially life-threatening complications
• Reduced medication efficacy: Inadequate control of schizophrenia symptoms due to leakage
• Treatment disruption: Need for additional medical interventions and medication adjustments

Do You Qualify for an Invega Syringe Lawsuit?

You may qualify for an Invega Syringe lawsuit if:

• You received an Invega Sustenna injection from a syringe included in the recall
• You experienced an infection or reduced medication efficacy after the injection
• The recalled syringe had NDC 50458-564-01 and specific lot numbers (9IBK000, 9IBK001, 9IBK002, 9IBK003, 9IBK004, 9IBK005, 9JBK000)
• You can provide medical documentation linking your injuries to the recalled Invega syringe

Evidence Required for an Invega Syringe Lawsuit

To successfully pursue an Invega Syringe lawsuit, you will need:

• Medical records documenting the Invega Sustenna injection
• Evidence that the injection came from a recalled lot
• Medical records showing infection or reduced medication efficacy
• Documentation of additional treatments required due to the defective syringe

Damages You Can Recover

Successful Invega Syringe lawsuits may result in compensation for:

• Medical expenses for treating infections or medication complications
• Lost wages due to additional medical care or worsening symptoms
• Pain and suffering caused by infections or psychiatric symptom recurrence
• Punitive damages against the manufacturer

Invega Syringe Recall Information

The recall affects Invega Sustenna (paliperidone palmitate 234 mg) Extended-Release Injectable Suspension with:

• NDC 50458-564-01 and lot numbers:
  • 9IBK000 (exp. 09/2011)
  • 9IBK001 (exp. 12/2011)
  • 9IBK002 (exp. 02/2012)
  • 9IBK003 (exp. 05/2012)
  • 9IBK004 (exp. 12/2012)
  • 9IBK005 (exp. 12/2012)
  • 9JBK000 (exp. 12/2012)
• Sample packages with NDC 50458-564-03 and lot numbers:
  • 9JBK000 (exp. 12/2011)
  • 9JBK001 (exp. 08/2012)
  • 9IBK000 (exp. 12/2011)
    The recall, announced by Johnson & Johnson’s Janssen unit on February 15, 2011, addresses cracks in the syringes that may not be visually detectable by consumers.

Statute of Limitations for Invega Syringe Lawsuits

The statute of limitations for filing an Invega Syringe lawsuit varies by state but typically ranges from one to several years after discovering harm caused by the recalled product. It’s crucial to consult with an attorney as soon as possible to ensure your case is filed within the legal time frame.

FAQs

1. What is Invega Sustenna?

Invega Sustenna is an injectable anti-psychotic medication used to treat schizophrenia. It’s administered by healthcare professionals into a muscle (upper arm or buttocks), with the first 2 doses given 1 week apart, followed by monthly injections.

2. What’s the difference between Invega and Invega Sustenna?

The difference is how long the drugs last in the body. Invega Sustenna lasts for 1 month, while Invega Trinza lasts for 3 months, and Invega Hayfera lasts for 6 months, requiring only two injections per year.

3. What should I do if I receive a recalled Invega Syringe?

If you believe you received an injection from a recalled Invega syringe, contact your healthcare provider immediately to discuss potential risks and monitoring for infection or reduced medication efficacy.

4. Can I join a class action lawsuit for Invega Syringe injuries?

The Product Liability Litigation Group at Schmidt & Clark, LLP is handling individual litigation nationwide rather than class action lawsuits. This approach allows for personalized representation based on your specific circumstances.

5. How much does it cost to hire a lawyer for an Invega Syringe lawsuit?

Schmidt & Clark, LLP handles cases on a contingency fee basis, meaning there are no upfront costs, and you only pay if your case results in compensation.

6. What compensation might I receive from an Invega Syringe lawsuit?

Compensation varies based on the severity of injuries, medical expenses, lost wages, and other factors. Your attorney can provide a more specific estimate based on your unique circumstances.

7. How long does an Invega Syringe lawsuit typically take?

The timeline for resolution varies widely depending on case complexity, evidence, and whether the case settles or goes to trial. Your attorney can provide a more accurate timeline based on your specific situation.

8. Who is responsible for the defective Invega Syringes?

Johnson & Johnson and its subsidiaries that manufactured the syringes are typically held responsible in these types of product liability cases.

9. What impact could a successful lawsuit have on manufacturers?

A successful lawsuit could lead to significant financial liability for manufacturers, potential changes in manufacturing processes, increased regulatory scrutiny, and may encourage other affected individuals to come forward.

10. Can I still file a lawsuit if my syringe wasn’t specifically recalled?

If you experienced similar injuries from an Invega syringe that wasn’t part of the recall, you may still have a case. Consult with an attorney to discuss your specific situation.

See all related product liability lawsuits our attorneys covered so far.

Take Action Now: Time-Sensitive Legal Claims

Time is limited to pursue legal action for injuries related to recalled Invega syringes. With statutes of limitations varying by state, it’s crucial to act promptly to protect your legal rights.

The Product Liability Litigation Group at Schmidt & Clark, LLP offers:

• Free, confidential consultations
• No upfront costs or fees
• Payment only if we win your case

Our experienced team of trial lawyers focuses on representing plaintiffs in Invega Syringe Recall lawsuits nationwide. We are currently accepting new infection and reduced efficacy cases in all 50 states.

[START YOUR FREE CASE REVIEW NOW]